Miltefosine

CAS No. 58066-85-6

Miltefosine( HePC )

Catalog No. M15130 CAS No. 58066-85-6

Miltefosine is used for the treatment of visceral and cutaneous leishmaniasis, and is undergoing clinical trials for this use in several other countries.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 42 In Stock
100MG 50 In Stock
200MG 77 In Stock
500MG 105 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Miltefosine
  • Note
    Research use only, not for human use.
  • Brief Description
    Miltefosine is used for the treatment of visceral and cutaneous leishmaniasis, and is undergoing clinical trials for this use in several other countries.
  • Description
    Miltefosine is used for the treatment of visceral and cutaneous leishmaniasis, and is undergoing clinical trials for this use in several other countries. Several medical agents have some efficacy against visceral or cutaneous leishmaniasis, however a 2005 survey concluded that miltefosine is the only effective oral treatment for both forms of leishmaniasis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    HePC
  • Pathway
    Angiogenesis
  • Target
    PKC
  • Recptor
    PKC
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    58066-85-6
  • Formula Weight
    407.58
  • Molecular Formula
    C21H46NO4P
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 82 mg/mL (201.19 mM); Water: 82 mg/mL (201.19 mM)
  • SMILES
    O=P(OCCCCCCCCCCCCCCCC)([O-])OCC[N+](C)(C)C
  • Chemical Name
    hexadecyl (2-(trimethylammonio)ethyl) phosphate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Uberall F, et al. Y Res, 1991, 51(3), 807-812.
molnova catalog
related products
  • 20-HETE

    20-HETE promotes cell proliferation and migration in cancer and can be used to study prostate tumors and cardiac hypertrophy by activating the protein kinase C pathway to increase FBXO10 expression.

  • AS2521780

    AS2521780 is a?potent, selective, orally bioavailable PKCθ inhibitor that inhibits combinant human PKCθ enzyme with IC50 of 0.48 nM.

  • PKCiota-IN-2

    PKCiota-IN-2 (PKCiota-IN-49) is a selective and potent PKCiota (PKC-ι) inhibitor with an IC50 of 2.8 nM. PKCiota-IN-2 also inhibits PKC-α and PKC-ε with IC50s of 71 nM and 350 nM, respectively